Biogen (BIIB) Non-Current Debt (2022 - 2024)
Historic Non-Current Debt for Biogen (BIIB) over the last 9 years, with Q4 2025 value amounting to $6.3 billion.
- Biogen's Non-Current Debt rose 3825.65% to $6.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.3 billion, marking a year-over-year increase of 3825.65%. This contributed to the annual value of $6.3 billion for FY2025, which is 3825.65% up from last year.
- Biogen's Non-Current Debt amounted to $6.3 billion in Q4 2025, which was up 3825.65% from $4.5 billion recorded in Q4 2024.
- Over the past 5 years, Biogen's Non-Current Debt peaked at $6.8 billion during Q4 2023, and registered a low of $4.5 billion during Q4 2024.
- For the 4-year period, Biogen's Non-Current Debt averaged around $6.0 billion, with its median value being $6.3 billion (2022).
- Per our database at Business Quant, Biogen's Non-Current Debt plummeted by 3301.32% in 2024 and then soared by 3825.65% in 2025.
- Quarter analysis of 4 years shows Biogen's Non-Current Debt stood at $6.3 billion in 2022, then grew by 8.08% to $6.8 billion in 2023, then tumbled by 33.01% to $4.5 billion in 2024, then soared by 38.26% to $6.3 billion in 2025.
- Its Non-Current Debt was $6.3 billion in Q4 2025, compared to $4.5 billion in Q4 2024 and $6.8 billion in Q4 2023.